A detailed history of Fil LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fil LTD holds 196,034 shares of CRL stock, worth $38.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
196,034
Previous 321,945 39.11%
Holding current value
$38.4 Million
Previous $66.5 Million 41.94%
% of portfolio
0.04%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $23.7 Million - $30.9 Million
-125,911 Reduced 39.11%
196,034 $38.6 Million
Q2 2024

Aug 13, 2024

SELL
$206.39 - $268.73 $15.5 Million - $20.2 Million
-75,100 Reduced 18.91%
321,945 $66.5 Million
Q1 2024

May 13, 2024

SELL
$203.52 - $273.43 $54.1 Million - $72.6 Million
-265,605 Reduced 40.08%
397,045 $108 Million
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $20.6 Million - $29.9 Million
125,000 Added 23.25%
662,650 $157 Million
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $40.5 Million - $45.3 Million
-208,281 Reduced 27.92%
537,650 $105 Million
Q2 2023

Aug 11, 2023

SELL
$183.71 - $210.25 $243,415 - $278,581
-1,325 Reduced 0.18%
745,931 $157 Million
Q1 2023

May 11, 2023

SELL
$191.89 - $259.92 $2.12 Million - $2.87 Million
-11,049 Reduced 1.46%
747,256 $151 Million
Q4 2022

Feb 13, 2023

BUY
$197.11 - $250.07 $5.79 Million - $7.34 Million
29,368 Added 4.03%
758,305 $165 Million
Q3 2022

Nov 10, 2022

SELL
$182.44 - $250.54 $13.7 Million - $18.9 Million
-75,349 Reduced 9.37%
728,937 $143 Million
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $381,723 - $565,488
1,870 Added 0.23%
804,286 $172 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $69 Million - $97.8 Million
270,046 Added 50.73%
802,416 $228 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $2.81 Million - $3.59 Million
7,994 Added 1.52%
532,370 $201 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $5.68 Million - $6.98 Million
15,240 Added 2.99%
524,376 $216 Million
Q2 2021

Aug 13, 2021

SELL
$294.17 - $371.65 $822,793 - $1.04 Million
-2,797 Reduced 0.55%
509,136 $188 Million
Q1 2021

May 14, 2021

SELL
$249.67 - $299.48 $74.6 Million - $89.5 Million
-298,974 Reduced 36.87%
511,933 $148 Million
Q4 2020

Feb 08, 2021

BUY
$222.0 - $252.62 $14.9 Million - $17 Million
67,238 Added 9.04%
810,907 $203 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $13.2 Million - $17 Million
-75,000 Reduced 9.16%
743,669 $168 Million
Q2 2020

Aug 13, 2020

SELL
$118.84 - $189.72 $2.97 Million - $4.74 Million
-25,000 Reduced 2.96%
818,669 $143 Million
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $1.04 Million - $1.88 Million
-10,565 Reduced 1.24%
843,669 $106 Million
Q4 2019

Feb 07, 2020

BUY
$126.05 - $152.76 $8.93 Million - $10.8 Million
70,813 Added 9.04%
854,234 $130 Million
Q3 2019

Nov 13, 2019

BUY
$125.07 - $143.67 $25 Million - $28.7 Million
200,000 Added 34.28%
783,421 $104 Million
Q2 2019

Aug 13, 2019

SELL
$123.4 - $148.55 $3.09 Million - $3.71 Million
-25,000 Reduced 4.11%
583,421 $82.8 Million
Q1 2019

May 13, 2019

SELL
$104.82 - $146.73 $5.24 Million - $7.34 Million
-50,000 Reduced 7.59%
608,421 $88.4 Million
Q4 2018

Feb 13, 2019

SELL
$105.09 - $137.23 $81.1 Million - $106 Million
-771,419 Reduced 53.95%
658,421 $74.5 Million
Q3 2018

Nov 09, 2018

SELL
$112.11 - $134.54 $35.6 Million - $42.7 Million
-317,681 Reduced 18.18%
1,429,840 $192 Million
Q2 2018

Aug 10, 2018

BUY
$102.37 - $117.25 $138 Million - $158 Million
1,348,124 Added 337.54%
1,747,521 $196 Million
Q1 2018

May 14, 2018

SELL
$98.19 - $115.2 $8.76 Million - $10.3 Million
-89,212 Reduced 18.26%
399,397 $42.6 Million
Q4 2017

Feb 12, 2018

BUY
$100.43 - $118.09 $17 Million - $20 Million
169,285 Added 53.01%
488,609 $53.5 Million
Q3 2017

Nov 13, 2017

SELL
$96.72 - $109.26 $9.49 Million - $10.7 Million
-98,141 Reduced 23.51%
319,324 $34.5 Million
Q2 2017

Aug 29, 2017

BUY
N/A
417,465
417,465 $42.2 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.